+5,295.0%
NVDA vs BBIO
+136.7%
+5,158.4%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -0.1% | +0.1% | 0.0% |
| 7D | -5.1% | -3.2% | -1.9% | -4.7% |
| 30D | -2.5% | -13.6% | +11.1% | -0.5% |
| 3M | +6.7% | +7.2% | -0.6% | +5.2% |
| 6M | +17.6% | +1.5% | +16.1% | +16.8% |
| YTD | +17.3% | -5.3% | +22.6% | +17.1% |
| 1Y | +23.5% | +37.7% | -14.2% | +16.5% |
| 3Y | +384.6% | +153.9% | +230.7% | +304.4% |
| 5Y | +875.4% | +43.9% | +831.5% | +583.8% |
| All | +5,295.0% | +136.7% | +5,158.4% | +2,955.4% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling